Igc Pharma

Igc Pharma company information, Employees & Contact Information

Updated May 2026

Quick answer

Igc Pharma is a Pharmaceutical Manufacturing company and founded in 2005. It has approximately 65 employees on record. Contact data was last refreshed in May 2026. Find Igc Pharma's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

IGC PHARMA is a Pharmaceutical company based in Maryland.

Company Details

Employees
65
Founded
-
Address
Potomac, Md, Us
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Potomac, MD
Looking for a particular Igc Pharma employee's phone or email?

Igc Pharma Questions

News

Major Alzheimer's Agitation Treatment Trial Expands: IGC Pharma Adds Oklahoma Research Site - Stock Titan

Major Alzheimer's Agitation Treatment Trial Expands: IGC Pharma Adds Oklahoma Research Site Stock Titan

IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada - Newswire.com

IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada Newswire.com

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates Yahoo Finance

CB1 receptor and psychosis: friend, foe, or both - Frontiers

CB1 receptor and psychosis: friend, foe, or both Frontiers

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health - BioSpace

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health BioSpace

Earnings call transcript: IGC Pharma Q2 2025 sees strategic growth in Alzheimer’s research - Investing.com

Earnings call transcript: IGC Pharma Q2 2025 sees strategic growth in Alzheimer’s research Investing.com

76% of Alzheimer's Patients Affected: IGC Pharma's Novel THC Treatment Hits Trial Milestone - Stock Titan

76% of Alzheimer's Patients Affected: IGC Pharma's Novel THC Treatment Hits Trial Milestone Stock Titan

IGC Pharma Welcomes Strategic Investment from Advisors - Yahoo Finance

IGC Pharma Welcomes Strategic Investment from Advisors Yahoo Finance

Major Alzheimer's Agitation Treatment Trial: IGC Pharma Expands CALMA Study to Leading Canadian Hospital - Stock Titan

Major Alzheimer's Agitation Treatment Trial: IGC Pharma Expands CALMA Study to Leading Canadian Hospital Stock Titan

IGC Pharma posts promising interim data for Alzheimer’s therapy - Clinical Trials Arena

IGC Pharma posts promising interim data for Alzheimer’s therapy Clinical Trials Arena

IGC Pharma Subsidiary Signs Asset Sale Agreement - TipRanks

IGC Pharma Subsidiary Signs Asset Sale Agreement TipRanks

IGC Pharma introduces AI platform to predict Alzheimer's risk - AuntMinnie

IGC Pharma introduces AI platform to predict Alzheimer's risk AuntMinnie

IGC Pharma heads towards a Phase I study for Alzheimer’s disease - Pharmaceutical Technology

IGC Pharma heads towards a Phase I study for Alzheimer’s disease Pharmaceutical Technology

Breakthrough: IGC Pharma's Alzheimer's Drug Shows 78% Sleep Improvement as Losses Drop $6M in 2025 - Stock Titan

Breakthrough: IGC Pharma's Alzheimer's Drug Shows 78% Sleep Improvement as Losses Drop $6M in 2025 Stock Titan

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM) - BioSpace

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM) BioSpace

IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology - Yahoo Finance

IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology Yahoo Finance

Major Alzheimer's Agitation Treatment Trial Expands: IGC Pharma Adds Key Research Site for IGC-AD1 Study - Stock Titan

Major Alzheimer's Agitation Treatment Trial Expands: IGC Pharma Adds Key Research Site for IGC-AD1 Study Stock Titan

What Makes IGC Pharma, Inc. (IGC) a New Buy Stock - Yahoo Finance

What Makes IGC Pharma, Inc. (IGC) a New Buy Stock Yahoo Finance

600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors - Stock Titan

600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors Stock Titan

Kd 3.95 μM: IGC Pharma's IGC-1C Modulates Tau LLPS, Inhibits and Dissolves Condensates - Stock Titan

Kd 3.95 μM: IGC Pharma's IGC-1C Modulates Tau LLPS, Inhibits and Dissolves Condensates Stock Titan

Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions - Frontiers

Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions Frontiers

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock - Business Wire

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock Business Wire

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline - BioSpace

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline BioSpace

IGC Pharma Catches Analyst Attention: $4.25 Target Set as Clinical Milestones Approach - Stock Titan

IGC Pharma Catches Analyst Attention: $4.25 Target Set as Clinical Milestones Approach Stock Titan

IGC Pharma Appoints Terry Lierman as an Independent Director to its Board of Directors - citybiz

IGC Pharma Appoints Terry Lierman as an Independent Director to its Board of Directors citybiz

IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - GlobeNewswire

IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. GlobeNewswire

IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease - ACCESS Newswire

IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease ACCESS Newswire

IGC Pharma Announces a $3 Million Private Placement of its Common Stock - Business Wire

IGC Pharma Announces a $3 Million Private Placement of its Common Stock Business Wire

India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors - citybiz

India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors citybiz

India Globalization Capital Appoints Jim Moran to Board - citybiz

India Globalization Capital Appoints Jim Moran to Board citybiz

IGC - IGC Pharma Inc Latest Stock News & Market Updates - Stock Titan

IGC - IGC Pharma Inc Latest Stock News & Market Updates Stock Titan

IGC Pharma, Inc. (IGC) - Zacks Investment Research

IGC Pharma, Inc. (IGC) Zacks Investment Research

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant